SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-23-000008
Filing Date
2023-08-08
Accepted
2023-08-08 16:31:05
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrdn-20230630.htm   iXBRL 10-Q 1404745
2 EX-31.1 ex311_2023-06.htm EX-31.1 11204
3 EX-31.2 ex312_2023-06.htm EX-31.2 12978
4 EX-32.1 ex321_2023-06.htm EX-32.1 9775
  Complete submission text file 0001590750-23-000008.txt   6712044

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrdn-20230630.xsd EX-101.SCH 44117
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrdn-20230630_cal.xml EX-101.CAL 57446
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrdn-20230630_def.xml EX-101.DEF 262510
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrdn-20230630_lab.xml EX-101.LAB 605826
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrdn-20230630_pre.xml EX-101.PRE 386860
57 EXTRACTED XBRL INSTANCE DOCUMENT vrdn-20230630_htm.xml XML 802991
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 231151922
SIC: 8071 Services-Medical Laboratories